Breast Neoplasms Clinical Trials in Shenyang, Liaoning
4 recruitingShenyang, Liaoning, China
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Breast Neoplasms
Bristol-Myers Squibb500 enrolled293 locationsNCT06926868
Recruiting
Phase 2
Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients
Breast Neoplasms
Shengjing Hospital30 enrolled1 locationNCT04983121
Recruiting
Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer
Breast Neoplasms
Shengjing Hospital500 enrolled2 locationsNCT04065321
Recruiting
Not Applicable
DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the Breast
Breast Neoplasms
Shengjing Hospital200 enrolled3 locationsNCT04052893